pre-IPO PHARMA

COMPANY OVERVIEW

Microbiotix is a privately-held, clinical stage biopharmaceutical company focused on the discovery and development of proprietary small molecule drugs that target serious infectious diseases.


LOCATION

  • Worchester, MA, USA

  • THERAPEUTIC AREAS

  • Infectious Disease

  • WEBSITE

    https://www.microbiotix.com/


    CAREER WEBSITE

    https://www.microbiotix.com/careers.htm


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Jun 7, 2018

    Microbiotix presents new data at the ASM Microbe 2018 Conference


    Sep 14, 2017

    Microbiotix and the AMR Centre Announce Co-Development Agreement Targeting Drug Resistant P. aeruginosa in Critically Ill Pneumonia Patients


    May 18, 2016

    Global Shigella Infections (Shigellosis) Pipeline Report 2016 - Review of Anacor Pharma, GSK, Microbiotix, Protein Potential and Visterra and Their Drug Profiles - Research and Markets


    Jan 2, 2013

    Microbiotix Announces Exclusive Worldwide Licensing Agreement for HCV NS5B Non-Nucleoside Polymerase Inhibitors


    For More Press Releases


    Google Analytics Alternative